🇺🇸 FDA
Patent

US 11571466

Compositions and methods for treating Gaucher disease

granted A61KA61K38/47A61K45/06

Quick answer

US patent 11571466 (Compositions and methods for treating Gaucher disease) held by Takeda Pharmaceutical Company Limited expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/47, A61K45/06, A61K9/0019, A61P